» Articles » PMID: 38916993

Complete Absence of GLUT1 Does Not Impair Human Terminal Erythroid Differentiation

Overview
Journal Blood Adv
Specialty Hematology
Date 2024 Jun 25
PMID 38916993
Authors
Affiliations
Soon will be listed here.
Abstract

The glucose transporter 1 (GLUT1) is 1 of the most abundant proteins within the erythrocyte membrane and is required for glucose and dehydroascorbic acid (vitamin C precursor) transport. It is widely recognized as a key protein for red cell structure, function, and metabolism. Previous reports highlighted the importance of GLUT1 activity within these uniquely glycolysis-dependent cells, in particular for increasing antioxidant capacity needed to avoid irreversible damage from oxidative stress in humans. However, studies of glucose transporter roles in erythroid cells are complicated by species-specific differences between humans and mice. Here, using CRISPR-mediated gene editing of immortalized erythroblasts and adult CD34+ hematopoietic progenitor cells, we generate committed human erythroid cells completely deficient in expression of GLUT1. We show that absence of GLUT1 does not impede human erythroblast proliferation, differentiation, or enucleation. This work demonstrates, to our knowledge, for the first time, generation of enucleated human reticulocytes lacking GLUT1. The GLUT1-deficient reticulocytes possess no tangible alterations to membrane composition or deformability in reticulocytes. Metabolomic analyses of GLUT1-deficient reticulocytes reveal hallmarks of reduced glucose import, downregulated metabolic processes and upregulated AMP-activated protein kinase signaling, alongside alterations in antioxidant metabolism, resulting in increased osmotic fragility and metabolic shifts indicative of higher oxidant stress. Despite detectable metabolic changes in GLUT1-deficient reticulocytes, the absence of developmental phenotype, detectable proteomic compensation, or impaired deformability comprehensively alters our understanding of the role of GLUT1 in red blood cell structure, function, and metabolism. It also provides cell biological evidence supporting clinical consensus that reduced GLUT1 expression does not cause anemia in GLUT1-deficiency syndrome.

References
1.
Nemkov T, Key A, Stephenson D, Earley E, Keele G, Hay A . Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro. Blood. 2024; 143(24):2517-2533. PMC: 11208298. DOI: 10.1182/blood.2024023983. View

2.
Thomas T, Stefanoni D, Dzieciatkowska M, Issaian A, Nemkov T, Hill R . Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients. J Proteome Res. 2020; 19(11):4455-4469. PMC: 7640979. DOI: 10.1021/acs.jproteome.0c00606. View

3.
Mohandas N, Gallagher P . Red cell membrane: past, present, and future. Blood. 2008; 112(10):3939-48. PMC: 2582001. DOI: 10.1182/blood-2008-07-161166. View

4.
Malleret B, Xu F, Mohandas N, Suwanarusk R, Chu C, Leite J . Significant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytes. PLoS One. 2013; 8(10):e76062. PMC: 3793000. DOI: 10.1371/journal.pone.0076062. View

5.
Furuse T, Mizuma H, Hirose Y, Kushida T, Yamada I, Miura I . A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain. Dis Model Mech. 2019; 12(9). PMC: 6765196. DOI: 10.1242/dmm.038828. View